drugset / Trial / NCT05906303

Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term

NCT05906303

Phase 1 Unknown 80 enrolled The Reading Hospital and Medical Center
RandomizedSingle-groupSingle-blindPrevention

Summary

Single blind, randomized control trial to determine benefit of caffeine and sodium benzoate on the second stage of labor

Timeline

Start
2023-12-01
Primary completion
2024-12-01
Completion
2025-02-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 125 mg Intravenous
Subject Sodium Benzoate Small molecule 125 mg Intravenous

Indications

No indication recorded.